Olema Oncology’s Post

Another big step forward as we move toward the 2nd quarter of 2024. We announced the partership with Caris Life Science, another example of embracing the megatrend of #bigdata #AIdrugdiscovry. This is an exciting time as we continue to work as one for patient. #Merckhealthcare #ADC #AI #Bigdata

Empower your oncology patients and sites like never before! 🌟 View below how digital trial methods are revolutionizing cancer research, by offering real-time insights, personalized care, and greater accessibility to cutting-edge treatments. Access the full case study here: https://lnkd.in/eKxBRzvJ ________ #oncology #clinicaltrials #clinicalresearch #digitalhealth

The high unmet medical need for early onset cancer has implications for the regulatory pathway and the perceived value of newly developed agents. Learn the nuanced considerations for developing and marketing a new treatment for cancer in younger adults in our upcoming webinar: https://ow.ly/hOzq50Qk9Er #earlyonsetcancer #oncology #drugdevelopment

The high unmet medical need for early onset cancer has implications for the regulatory pathway and the perceived value of newly developed agents. Learn the nuanced considerations for developing and marketing a new treatment for cancer in younger adults in our upcoming webinar: https://ow.ly/hOzq50Qk9Er #earlyonsetcancer #oncology #drugdevelopment

Which titles and topics at ESMO24 will shift the needle in oncology clinical practice?   ESMO24 is packed with cutting-edge research and developments, the Axiom Team has highlighted a few key topics/ titles to explore.   If attending, stop by booth 334 for a quick chat on what these data mean for you and your organization. #AxiomThinkTank #ESMO24 #Oncology #OncologyResearch #CancerCareInnovation #OncologyUpdates #MedicalConference #PrecisionOncology #CancerResearch

Check out the key conferences of 2023 where trial data is discussed alongside commentaries from oncology experts on X. 💫 Gain insights and stay updated on the latest developments in oncology with LARVOL. #LARVOL #Oncology #CancerResearch #OncologyConferences

The high unmet medical need for early onset cancer has implications for the regulatory pathway and the perceived value of newly developed agents. Learn the nuanced considerations for developing and marketing a new treatment for cancer in younger adults in our upcoming webinar: https://ow.ly/hOzq50Qk9Er #earlyonsetcancer #oncology #drugdevelopment

Did you know that there are over 100 different types of cancer, each with unique challenges and treatment approaches? At #ESMO2024, I’m eager to explore the latest research and innovations that can help us address these challenges. Looking forward to attending #ESMO24 and meeting you there! #Oncology #MedicalEducation #drugdevelopment #MedicalAffairs #RocheOncology

Learn the key oncology abstracts and datasets to watch out for at ASCO 2024, the world's largest cancer conference. Join our webinar on May 28 for insights from Bloomberg Intelligence analysts. Register here: https://bloom.bg/4dKLNRu #corporations #oncology #data #ASCO24

🔑 "The key to advancing precision oncology is to democratize the data." 🔑 Stacy Hurt, Parexel's Chief Patient Officer and a stage 4 cancer survivor, highlights three things we MUST do to ensure all patients can potentially benefit from precision oncology in our New Medicines, Novel Insights report: https://lnkd.in/eA_htqMx #PatientData #Oncology #NovelInsights